June 19, 2014. A new study claiming to show that antidepressant warnings have backfired has resulted in media quoting researchers’ speculation as if it is fact. It isn’t.
Read More »On Medical Treatments & Products
NCHR Testimony to FDA on VBLOC MAESTRO Device
June 17, 2014. We all know that obesity is often debilitating. The VBLOC device is an innovative way of addressing this important health concern but the question is: how well does it work and does its benefits outweigh its risks?
Read More »Statement of Dr. Diana Zuckerman on FDA’s Proposed Order for Pelvic Mesh
April 30, 2014. We strongly support the FDA decision to require proof of safety and effectiveness of surgical mesh for pelvic organ prolapse (POP) in clinical trials.
Read More »Statement of Dr. Diana Zuckerman Regarding FDA’s Announcement About Power Morcellation Devices for Uterine Fibroids and Other Uterine Surgery
April 17, 2014. We thank FDA for discouraging surgeons from using an FDA-approved device for women with uterine fibroids.
Read More »Coalition Letter to FDA Center for Drug Evaluation and Research About Flibanserin or “Pink Viagra”
April 8, 2014. As members of the Patient, Consumer, and Public Health Coalition, we are writing to support the agency’s evidence-based evaluation and decision regarding flibanserin.
Read More »